Speech and swallowing disorders in Parkinson’s disease – is there a link?
Objective: To determine: 1.If acoustic speech analysis can be a method of oropharyngeal dysphagia detection. 2.Which acoustic parameters and to what extent correlate with fiberoptic…Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder
Objective: To assess whether changes in brain capillary function measured with magnetic resonance imaging (MRI) can be detected in patients with REM sleep behavior disorder…Long-term changes in myocardial sympathetic innervation and function in synucleinopathies
Objective: Describe long-term trends in indices of cardiac sympathetic innervation and function in synucleinopathies. Background: A group of neurodegenerative diseases including Parkinson disease (PD), pure…NEURONAL NETWORK UNDERLYING DYSPHAGIA IN PARKINSON’S DISEASE
Objective: We aimed to investigate whether chewing and swallowing difficulties are associated with changes in cortical thickness. Background: Chewing and swallowing difficulties are a common…Singing – tune into self-regulation: A holistic system perspective
Objective: The aim of the single case experimental study [1] was to examine the treatment of PD under a more holistic systemic perspective similar to…Slow-Motion Analysis of Repetitive Tapping (SMART): a pilot study of a new measurement of bradykinesia
Objective: To assess repetitive tapping movements (RTM) using a slow motion camera and compare them with a clinician visual impression in people that have been…Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
Objective: Evaluate if patients fulfill the recently developed “5-2-1” screening criteria for advanced Parkinson’s Disease (APD)[1] prior to treatment with levodopa-carbidopa intestinal gel (LCIG) and…Effect of an Increase in Dose of Istradefylline, an A2A Receptor Antagonist, in Levodopa (LD)-Treated Patients with Parkinson’s Disease (PD)
Objective: To observe whether increasing the istradefylline dose from 20 to 40mg/day provides more patients with meaningful clinical responses. Background: Istradefylline, a well-tolerated selective adenosine…GLYCOPAR – A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of glycopyrrolate for moderate-to-severe sialorrhea in Parkinson’s disease
Objective: To assess the 3-month efficacy and safety of glycopyrrolate for moderate-to-severe sialorrhea in Parkinson’s disease. Background: A systematic review reported that sialorrhea affects approximately…Spectrum of motor complications in advanced Parkinson’s disease: data from a large Romanian case series evaluated for suitability for device aided therapy
Objective: The objective was to describe the spectrum of motor complications in a large cohort of patients with advanced Parkinson’s Disease (APD) who received at…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 405
- Next Page »